Ankerstar Wealth’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4
Closed -$1.49K – 1091
2026
Q2
$1.49K Sell
4
-1
-20% -$299 ﹤0.01% 427
2026
Q1
$1.29K Buy
5
+1
+25% +$266 ﹤0.01% 411
2025
Q4
$986 Buy
+4
New +$842 ﹤0.01% 494

Other funds holding KRYS

Ankerstar Wealth's KRYS Position: Q3 2026 in Review

Ankerstar Wealth sold out of Krystal Biotech (KRYS) in Q3 2026, closing a stake of 4 shares — an estimated $1.49K sold.

Ankerstar Wealth first reported a position in KRYS in Q4 2025 and held it in 3 quarters. The position peaked at $1.49K in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Ankerstar Wealth reported no remaining Krystal Biotech position as of Q3 2026 after selling out during the quarter.
  • Ankerstar Wealth sold 4 Krystal Biotech shares in Q3 2026, an estimated $1.49K.
  • Ankerstar Wealth first reported a position in Krystal Biotech in Q4 2025 and held it in 3 quarters.
  • Ankerstar Wealth's Krystal Biotech position peaked at $1.49K in Q2 2026.
  • 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.